Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-821,300 Reduced 81.69%
184,100 $0
Q2 2024

Aug 15, 2024

BUY
N/A
779,800 Added 345.66%
1,005,400 $0
Q1 2024

May 07, 2024

BUY
N/A
193,300 Added 598.45%
225,600 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-81,000 Reduced 71.49%
32,300 $0
Q3 2023

Nov 14, 2023

BUY
N/A
113,300 New
113,300 $0
Q1 2023

May 16, 2023

BUY
N/A
13,400 Added 6.88%
208,200 $0
Q4 2022

Feb 14, 2023

BUY
N/A
30,500 Added 18.56%
194,800 $0
Q3 2022

Nov 14, 2022

BUY
N/A
38,600 Added 30.71%
164,300 $868,000
Q2 2022

Aug 15, 2022

BUY
N/A
84,300 Added 203.62%
125,700 $533,000
Q1 2022

May 16, 2022

SELL
N/A
-19,600 Reduced 32.13%
41,400 $145,000
Q4 2021

Feb 14, 2022

BUY
N/A
61,000 New
61,000 $406,000

About ARS PHARMACEUTICALS, INC. COMM


  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.